Weill Cornell Medicine has received a $1.27 million grant from the United States Department of Defense to develop treatment for a rare but devastating eye condition largely affecting military personnel who suffer traumatic eye injuries in combat.
A patient living with HIV who received a blood stem cell transplant for high-risk acute myeloid leukemia has been free of the virus for 14 months after stopping HIV antiretroviral drug treatment, suggesting a cure, according to the Weill Cornell Medicine and New York-Presbyterian physician-scientists who performed the transplant and managed her care.
What can faculty, students and community members be doing in response to institutional racism and its role in shaping health equity? A webinar organized by the Cornell Center for Health Equity will examine this question.
Cornell Atkinson is soliciting nominations for The Earthshot Prize, a new global award supported by The Duke and Duchess of Cambridge to tackle the world’s biggest environmental challenges.
The simple technique was associated with a 56% reduction in irregular heart rhythm that can lead to stroke, with no added risks, according to a Weill Cornell Medicine study.
Students living on campus have a new resource for support when they are experiencing distress, with the launch of the university’s Community Response Team at the start of this semester.
As more states legalize cannabis for medical or recreational purposes, its use during pregnancy is increasing – along with the potential forabuse or dependence.
Treatment with the amino acid arginine enhanced the effectiveness of radiation therapy in cancer patients with brain metastases in a clinical trial from investigators at Weill Cornell Medicine and Angel H. Roffo Cancer Institute.
